title: New Alzheimer amyloid beta responsive genes identified in human neuroblastoma cells by hierarchical clustering.
abstract: Alzheimer's disease (AD) is characterized by neuronal degeneration and cell loss. Abeta(42), in contrast to Abeta(40), is thought to be the pathogenic form triggering the pathological cascade in AD. In order to unravel overall gene regulation we monitored the transcriptomic responses to increased or decreased Abeta(40) and Abeta(42) levels, generated and derived from its precursor C99 (C-terminal fragment of APP comprising 99 amino acids) in human neuroblastoma cells. We identified fourteen differentially expressed transcripts by hierarchical clustering and discussed their involvement in AD. These fourteen transcripts were grouped into two main clusters each showing distinct differential expression patterns depending on Abeta(40) and Abeta(42) levels. Among these transcripts we discovered an unexpected inverse and strong differential expression of neurogenin 2 (NEUROG2) and KIAA0125 in all examined cell clones. C99-overexpression had a similar effect on NEUROG2 and KIAA0125 expression as a decreased Abeta(42)/Abeta(40) ratio. Importantly however, an increased Abeta(42)/Abeta(40) ratio, which is typical of AD, had an inverse expression pattern of NEUROG2 and KIAA0125: An increased Abeta(42)/Abeta(40) ratio up-regulated NEUROG2, but down-regulated KIAA0125, whereas the opposite regulation pattern was observed for a decreased Abeta(42)/Abeta(40) ratio. We discuss the possibilities that the so far uncharacterized KIAA0125 might be a counter player of NEUROG2 and that KIAA0125 could be involved in neurogenesis, due to the involvement of NEUROG2 in developmental neural processes.
authors.affiliation: Center for Molecular Biology of the University of Heidelberg (ZMBH), Heidelberg, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Uhrig
authors.forename: Carina
authors.initials: C
authors.lastname: Ittrich
authors.forename: Verena
authors.initials: V
authors.lastname: Wiedmann
authors.forename: Yuri
authors.initials: Y
authors.lastname: Knyazev
authors.forename: Annette
authors.initials: A
authors.lastname: Weninger
authors.forename: Matthias
authors.initials: M
authors.lastname: Riemenschneider
authors.forename: Tobias
authors.initials: T
authors.lastname: Hartmann
mesh_terms: D016229:Amyloid beta-Peptides / Q000235:genetics*; D051792:Basic Helix-Loop-Helix Proteins / Q000235:genetics; D045744:Cell Line, Tumor; D016000:Cluster Analysis; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009419:Nerve Tissue Proteins / Q000235:genetics; D009447:Neuroblastoma / Q000235:genetics / Q000473:pathology*; D016133:Polymerase Chain Reaction
chemical_list: D016229:Amyloid beta-Peptides; D051792:Basic Helix-Loop-Helix Proteins; D009419:Nerve Tissue Proteins; C491183:NEUROG2 protein, human
references.citation: Mol Cell Neurosci. 1996;8(4):221-41
references.pmid: 9000438
references.citation: Am J Pathol. 1995 Oct;147(4):934-46
references.pmid: 7573369
references.citation: Hypertension. 1999 Jun;33(6):1414-9
references.pmid: 10373225
references.citation: Ann Neurol. 1995 Mar;37(3):287-8
references.pmid: 7695227
references.citation: J Cell Biol. 1989 Dec;109(6 Pt 1):2929-37
references.pmid: 2687290
references.citation: J Neurosci. 2007 Jun 20;27(25):6771-80
references.pmid: 17581964
references.citation: Genome Biol. 2004;5(10):R80
references.pmid: 15461798
references.citation: Nat Cell Biol. 2005 Nov;7(11):1118-23
references.pmid: 16227967
references.citation: Exp Neurol. 2007 Mar;204(1):77-87
references.pmid: 17070803
references.citation: J Comp Neurol. 2006 Mar 1;495(1):70-83
references.pmid: 16432899
references.citation: J Biol Chem. 2003 Apr 11;278(15):13077-85
references.pmid: 12556458
references.citation: Arch Dis Child. 2008 Oct;93(10):890-8
references.pmid: 18591185
references.citation: Nat Genet. 2007 Dec;39(12):1488-93
references.pmid: 17994018
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):343-7
references.pmid: 14660786
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4710-5
references.pmid: 11296300
references.citation: J Biol Chem. 2007 Jun 1;282(22):16146-54
references.pmid: 17403680
references.citation: DNA Res. 1995 Aug 31;2(4):167-74, 199-210
references.pmid: 8590280
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15014-9
references.pmid: 11752450
references.citation: J Biol Chem. 2006 May 5;281(18):12485-94
references.pmid: 16537537
references.citation: Nature. 2002 Apr 4;416(6880):535-9
references.pmid: 11932745
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3053-8
references.pmid: 10077635
references.citation: Development. 2004 Jul;131(13):3133-45
references.pmid: 15175243
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):780-5
references.pmid: 16407118
references.citation: Neuron. 2003 Jul 3;39(1):13-25
references.pmid: 12848929
references.citation: Cytogenet Genome Res. 2007;119(3-4):171-84
references.pmid: 18253026
references.citation: Development. 2006 Feb;133(3):495-505
references.pmid: 16410412
references.citation: Development. 2008 Jun;135(11):2031-41
references.pmid: 18448566
references.citation: Brain Res. 2000 May 26;865(2):157-67
references.pmid: 10821917
references.citation: Stat Appl Genet Mol Biol. 2004;3:Article3
references.pmid: 16646809
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13363-7
references.pmid: 15340159
references.citation: Biochem Soc Trans. 2002 Aug;30(4):552-7
references.pmid: 12196135
references.citation: Cancer Res. 1978 Nov;38(11 Pt 1):3751-7
references.pmid: 29704
references.citation: Neurology. 1993 Aug;43(8):1467-72
references.pmid: 8350998
references.citation: Neuron. 2001 Aug 2;31(2):203-17
references.pmid: 11502253
references.citation: J Natl Cancer Inst. 1983 Oct;71(4):741-7
references.pmid: 6137586
references.citation: FASEB J. 2000 Nov;14(14):2213-20
references.pmid: 11053242